Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 819636, 7 pages
http://dx.doi.org/10.1155/2012/819636
Research Article

Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C

1Department of Central Laboratory, The Second Part of First Hospital, Jilin University, Changchun 130032, China
2Department of Hepatology, First Hospital, Jilin University, Changchun 130032, China

Received 23 August 2011; Revised 18 October 2011; Accepted 19 October 2011

Academic Editor: Giamila Fantuzzi

Copyright © 2012 Juan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Alberti, L. Chemello, and L. Benvegnù, “Natural history of hepatitis C,” Journal of Hepatology, vol. 31, no. 1, pp. 17–24, 1999. View at Google Scholar · View at Scopus
  2. S. D. Crockett and E. B. Keeffe, “Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection,” Annals of Clinical Microbiology and Antimicrobials, vol. 4, article 13, 12 pages, 2005. View at Publisher · View at Google Scholar
  3. B. Rehermann and M. Nascimbeni, “Immunology of hepatitis B virus and hepatitis C virus infection,” Nature Reviews Immunology, vol. 5, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Rehermann, “Interaction between the hepatitis C virus and the immune system,” Seminars in Liver Disease, vol. 20, no. 2, pp. 127–141, 2000. View at Google Scholar · View at Scopus
  5. P. Ciborowski and H. E. Gendelman, “Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis,” Current HIV Research, vol. 4, no. 3, pp. 279–291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Martini, C. Agrati, G. D'Offizi, and F. Poccia, “HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 2, pp. 269–276, 2005. View at Google Scholar · View at Scopus
  7. M. I. Gonzalez, N. Rubinstein, J. M. Ilarregui, M. A. Toscano, N. A. Sanjuan, and G. A. Rabinovich, “Regulated expression of galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 4, pp. 615–623, 2005. View at Google Scholar · View at Scopus
  8. E. Schvoerer, M. C. Navas, C. Thumann et al., “Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy,” Journal of Medical Virology, vol. 70, no. 4, pp. 588–593, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Katia, U. Claudio, D. Margherita et al., “Modulation of serum interleukin-18 concentrations and hepatitis B virus DNA levels during interferon therapy in patients with hepatitis be-antigen-positive chronic hepatitis B,” Annals of Clinical & Laboratory Science, vol. 36, pp. 144–150, 2006. View at Google Scholar
  10. H. Wright, P. Alex, T. Nguyen et al., “Multiplex cytokine profiling of initial therapeutic response in patients with chronic hepatitis C virus infection,” Digestive Diseases and Sciences, vol. 50, no. 10, pp. 1793–1803, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Schmitz, A. Owyang, E. Oldham et al., “IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines,” Immunity, vol. 23, no. 5, pp. 479–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Alves-Filho, F. Sônego, F. O. Souto et al., “Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection,” Nature Medicine, vol. 16, no. 6, pp. 708–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. X. Yang, Y. Liang, W. Q. Xi, C. Li, and R. Zhong, “Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population,” Clinical and Experimental Medicine, vol. 11, pp. 75–80, 2011. View at Google Scholar
  14. A. Becerra, R. V. Warke, N. de Bosch, A. L. Rothman, and I. Bosch, “Elevated levels of soluble ST2 protein in dengue virus infected patients,” Cytokine, vol. 41, no. 2, pp. 114–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Miyagaki, M. Sugaya, H. Yokobayashi et al., “High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection,” Journal of Investigative Dermatology, vol. 131, no. 3, pp. 794–796, 2011. View at Publisher · View at Google Scholar
  16. M. Sherman, S. Shafran, K. Burak et al., “Management of chronic hepatitis B: consensus guidelines,” Canadian Journal of Gastroenterology, vol. 21, pp. 25C–34C, 2007. View at Google Scholar · View at Scopus
  17. M. Sarasin-Filipowicz, “Interferon therapy of hepatitis C: molecular insights into success and failure,” Swiss Medical Weekly, vol. 140, no. 1-2, pp. 3–11, 2010. View at Google Scholar · View at Scopus
  18. E. Morgan, R. Varro, H. Sepulveda et al., “Cytometric bead array: a multiplexed assay platform with applications in various areas of biology,” Clinical Immunology, vol. 110, no. 3, pp. 252–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Tárnok, J. Hambsch, R. Chen, and R. Varro, “Cytometric bead array to measure six cytokines in twenty-five microliters of serum,” Clinical Chemistry, vol. 49, no. 6, pp. 1000–1002, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Li, M. Yuan, Z. Huang, J. Fan et al., “Novel double-antigen sandwich immunoassay for human hepatitis B core antibody,” Clinical and Vaccine Immunology, vol. 17, no. 3, pp. 464–469, 2010. View at Google Scholar
  21. H. E. Barksby, S. R. Lea, P. M. Preshaw, and J. J. Taylor, “The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders,” Clinical and Experimental Immunology, vol. 149, no. 2, pp. 217–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Y. Mok, F. P. Huang, D. Xu et al., “Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus,” Rheumatology, vol. 49, no. 3, Article ID kep402, pp. 520–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Y. Liew, N. I. Pitman, and I. B. McInnes, “Disease-associated functions of IL-33: the new kid in the IL-1 family,” Nature Reviews Immunology, vol. 10, no. 2, pp. 103–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Louten, A. L. Rankin, and Y. Li, “Endogenous IL-33 enhances Th2 cytokine production and T-cell responses duringallergic airway inflammation,” International Immunology, vol. 23, no. 5, pp. 307–315, 2011. View at Publisher · View at Google Scholar
  25. V. Volarevic, M. Mitrovic, and M. Milovanovic, “Protective role of IL-33/ST2 axis in Con A-induced hepatitis,” Journal of Hepatology, vol. 56, no. 1, pp. 26–33, 2012. View at Publisher · View at Google Scholar
  26. M. I. Arshad, M. Rauch, A. L'Helgoualc'h et al., “NKT cells are required to induce high IL-33 expression in hepatocytes during Con A-induced acute hepatitis,” European Journal of Immunology, vol. 41, no. 8, pp. 2341–2348, 2011. View at Publisher · View at Google Scholar
  27. P. Marvie, M. Lisbonne, A. L'Helgoualc'h et al., “Interleukin-33 overexpression is associated with liver fibrosis in mice and humans,” Journal of Cellular and Molecular Medicine, vol. 14, no. 6, pp. 1726–1739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Roth, M. Zimmermann, B. A. Lubsczyk et al., “Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure,” Journal of Surgical Research, vol. 163, no. 2, pp. e79–e83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. H. Li, A. Kumanogoh, T. M. Cao, J. R. Parnes, and J. M. Cullen, “Woodchuck interleukin-6 gene: structure, characterization, and biologic activity,” Gene, vol. 342, no. 1, pp. 157–164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ghoneum and M. Matsuura, “Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/Biobran),” International Journal of Immunopathology and Pharmacology, vol. 17, no. 3, pp. 283–292, 2004. View at Google Scholar · View at Scopus
  31. M. Frese, V. Schwärzle, K. Barth et al., “Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs,” Hepatology, vol. 35, no. 3, pp. 694–703, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Y. Chun, J. W. Chung, H. A. Kim et al., “Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 27, no. 5, pp. 461–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Jiang, Z. Ma, G. Xin et al., “Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil,” Mediators of Inflammation, vol. 2010, 2010. View at Publisher · View at Google Scholar
  34. E. Bourgeois, L. P. Van, M. Samson et al., “The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production,” European Journal of Immunology, vol. 39, no. 4, pp. 1046–1055, 2009. View at Publisher · View at Google Scholar · View at Scopus